170 related articles for article (PubMed ID: 20610881)
1. Assessment of chimeric mice with humanized liver as a tool for predicting circulating human metabolites.
Kamimura H; Nakada N; Suzuki K; Mera A; Souda K; Murakami Y; Tanaka K; Iwatsubo T; Kawamura A; Usui T
Drug Metab Pharmacokinet; 2010; 25(3):223-35. PubMed ID: 20610881
[TBL] [Abstract][Full Text] [Related]
2. Chimeric mice with humanized liver.
Katoh M; Tateno C; Yoshizato K; Yokoi T
Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
[TBL] [Abstract][Full Text] [Related]
3. Application of chimeric mice with humanized liver for predictive ADME.
Katoh M; Yokoi T
Drug Metab Rev; 2007; 39(1):145-57. PubMed ID: 17364883
[TBL] [Abstract][Full Text] [Related]
4. Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity.
Strom SC; Davila J; Grompe M
Methods Mol Biol; 2010; 640():491-509. PubMed ID: 20645070
[TBL] [Abstract][Full Text] [Related]
5. CYP2C9-catalyzed metabolism of S-warfarin to 7-hydroxywarfarin in vivo and in vitro in chimeric mice with humanized liver.
Inoue T; Nitta K; Sugihara K; Horie T; Kitamura S; Ohta S
Drug Metab Dispos; 2008 Dec; 36(12):2429-33. PubMed ID: 18784266
[TBL] [Abstract][Full Text] [Related]
6. Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics.
Sanoh S; Ohta S
Biopharm Drug Dispos; 2014 Mar; 35(2):71-86. PubMed ID: 24114658
[TBL] [Abstract][Full Text] [Related]
7. Application of chimeric mice with humanized liver for study of human-specific drug metabolism.
Bateman TJ; Reddy VG; Kakuni M; Morikawa Y; Kumar S
Drug Metab Dispos; 2014 Jun; 42(6):1055-65. PubMed ID: 24700822
[TBL] [Abstract][Full Text] [Related]
8. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites.
Wang WW; Khetani SR; Krzyzewski S; Duignan DB; Obach RS
Drug Metab Dispos; 2010 Oct; 38(10):1900-5. PubMed ID: 20595376
[TBL] [Abstract][Full Text] [Related]
9. Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.
Kitamura S; Sugihara K
Xenobiotica; 2014 Jan; 44(2):123-34. PubMed ID: 24329499
[TBL] [Abstract][Full Text] [Related]
10. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
[TBL] [Abstract][Full Text] [Related]
11. Generation of major human excretory and circulating drug metabolites using a hepatocyte relay method.
Ballard TE; Orozco CC; Obach RS
Drug Metab Dispos; 2014 May; 42(5):899-902. PubMed ID: 24608634
[TBL] [Abstract][Full Text] [Related]
12. In vivo induction of human cytochrome P450 3A4 by rifabutin in chimeric mice with humanized liver.
Katoh M; Watanabe M; Tabata T; Sato Y; Nakajima M; Nishimura M; Naito S; Tateno C; Iwasaki K; Yoshizato K; Yokoi T
Xenobiotica; 2005 Sep; 35(9):863-75. PubMed ID: 16308281
[TBL] [Abstract][Full Text] [Related]
13. Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities.
Zhang RR; Zheng YW; Li B; Tsuchida T; Ueno Y; Nie YZ; Taniguchi H
Stem Cell Res Ther; 2015 Mar; 6(1):49. PubMed ID: 25889844
[TBL] [Abstract][Full Text] [Related]
14. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of cytochrome P450 and glucuronidation activities in hepatocytes isolated from liver-humanized mice.
Yamasaki C; Kataoka M; Kato Y; Kakuni M; Usuda S; Ohzone Y; Matsuda S; Adachi Y; Ninomiya S; Itamoto T; Asahara T; Yoshizato K; Tateno C
Drug Metab Pharmacokinet; 2010; 25(6):539-50. PubMed ID: 20930422
[TBL] [Abstract][Full Text] [Related]
16. Assessment of chimeric mice with humanized livers in new drug development: generation of pharmacokinetics, metabolism and toxicity data for selecting the final candidate compound.
Kamimura H; Ito S
Xenobiotica; 2016; 46(6):557-69. PubMed ID: 26444900
[TBL] [Abstract][Full Text] [Related]
17. Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.
Dalvie D; Obach RS; Kang P; Prakash C; Loi CM; Hurst S; Nedderman A; Goulet L; Smith E; Bu HZ; Smith DA
Chem Res Toxicol; 2009 Feb; 22(2):357-68. PubMed ID: 19146377
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver.
Kato S; Shah A; Plesescu M; Miyata Y; Bolleddula J; Chowdhury S; Zhu X
Drug Metab Dispos; 2020 Oct; 48(10):934-943. PubMed ID: 32665417
[TBL] [Abstract][Full Text] [Related]
19. Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery.
Naritomi Y; Sanoh S; Ohta S
Drug Metab Pharmacokinet; 2018 Feb; 33(1):31-39. PubMed ID: 29183653
[TBL] [Abstract][Full Text] [Related]
20. Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction.
Nishimura T; Hu Y; Wu M; Pham E; Suemizu H; Elazar M; Liu M; Idilman R; Yurdaydin C; Angus P; Stedman C; Murphy B; Glenn J; Nakamura M; Nomura T; Chen Y; Zheng M; Fitch WL; Peltz G
J Pharmacol Exp Ther; 2013 Feb; 344(2):388-96. PubMed ID: 23143674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
